Panjon Ltd
Incorporated in 1983, Panjon Ltd manufactures and trades consumer and pharmaceutical products
- Market Cap ₹ 31.4 Cr.
- Current Price ₹ 20.3
- High / Low ₹ 21.8 / 11.9
- Stock P/E 314
- Book Value ₹ 8.74
- Dividend Yield 0.00 %
- ROCE 1.23 %
- ROE 6.20 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of -21.2% over past five years.
- Company has a low return on equity of -7.27% over last 3 years.
- Debtor days have increased from 71.1 to 93.5 days.
- Working capital days have increased from 355 days to 511 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15.86 | 18.76 | 19.29 | 19.47 | 12.26 | 13.98 | 20.10 | 25.94 | 26.43 | 14.49 | 8.41 | 6.09 | 8.65 | |
16.78 | 19.59 | 19.15 | 22.54 | 12.35 | 14.00 | 19.68 | 25.63 | 26.11 | 14.30 | 12.45 | 6.09 | 8.76 | |
Operating Profit | -0.92 | -0.83 | 0.14 | -3.07 | -0.09 | -0.02 | 0.42 | 0.31 | 0.32 | 0.19 | -4.04 | 0.00 | -0.11 |
OPM % | -5.80% | -4.42% | 0.73% | -15.77% | -0.73% | -0.14% | 2.09% | 1.20% | 1.21% | 1.31% | -48.04% | 0.00% | -1.27% |
1.27 | 1.04 | 0.02 | -1.51 | 0.43 | 0.52 | 0.21 | 0.36 | 0.29 | 0.33 | 0.30 | 0.38 | 0.42 | |
Interest | 0.06 | 0.05 | 0.00 | 0.00 | 0.17 | 0.19 | 0.28 | 0.24 | 0.15 | 0.10 | 0.07 | 0.05 | 0.04 |
Depreciation | 0.23 | 0.09 | 0.08 | 0.13 | 0.14 | 0.13 | 0.11 | 0.15 | 0.27 | 0.23 | 0.20 | 0.21 | 0.17 |
Profit before tax | 0.06 | 0.07 | 0.08 | -4.71 | 0.03 | 0.18 | 0.24 | 0.28 | 0.19 | 0.19 | -4.01 | 0.12 | 0.10 |
Tax % | -233.33% | 14.29% | 312.50% | 27.18% | -1,133.33% | 33.33% | 50.00% | 53.57% | 115.79% | 47.37% | -3.49% | -575.00% | |
0.20 | 0.06 | -0.17 | -3.43 | 0.36 | 0.12 | 0.12 | 0.14 | -0.03 | 0.10 | -4.15 | 0.81 | 0.10 | |
EPS in Rs | 0.19 | 0.06 | -0.11 | -2.21 | 0.23 | 0.08 | 0.08 | 0.09 | -0.02 | 0.06 | -2.68 | 0.52 | 0.07 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -11% |
5 Years: | -21% |
3 Years: | -39% |
TTM: | 35% |
Compounded Profit Growth | |
---|---|
10 Years: | 30% |
5 Years: | 47% |
3 Years: | 207% |
TTM: | 102% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 42% |
Return on Equity | |
---|---|
10 Years: | -3% |
5 Years: | -4% |
3 Years: | -7% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.48 | 10.48 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 |
Reserves | 3.98 | 4.04 | 8.85 | 0.52 | 0.89 | 1.00 | 1.13 | 1.27 | 1.23 | 1.31 | -2.84 | -2.02 | -1.96 |
2.41 | 8.32 | 1.67 | 1.52 | 1.41 | 1.26 | 1.89 | 1.84 | 1.56 | 1.33 | 0.81 | 0.78 | 1.61 | |
2.18 | 1.12 | 1.39 | 0.51 | 0.24 | 0.28 | 0.29 | 0.34 | 0.92 | 1.12 | 0.58 | 0.64 | 0.80 | |
Total Liabilities | 19.05 | 23.96 | 27.41 | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 15.95 |
5.70 | 5.66 | 5.69 | 0.92 | 0.84 | 0.74 | 0.72 | 0.87 | 1.12 | 0.96 | 0.95 | 0.91 | 1.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.18 | 1.18 | 1.18 | 1.08 | 1.08 | 1.08 | 1.09 | 1.09 | 1.08 | 1.07 | 1.07 | 1.08 | 1.08 |
12.17 | 17.12 | 20.54 | 16.05 | 16.12 | 16.22 | 17.00 | 16.99 | 17.01 | 17.23 | 12.03 | 12.91 | 13.87 | |
Total Assets | 19.05 | 23.96 | 27.41 | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 15.95 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-5.92 | -3.48 | 0.89 | -0.20 | 0.18 | -0.17 | 0.49 | 0.35 | 0.34 | 1.82 | 0.04 | ||
-0.05 | -0.10 | 4.74 | -0.06 | -0.04 | -0.08 | -0.31 | -0.51 | -0.06 | -0.19 | -0.19 | ||
5.94 | 3.44 | -5.14 | -0.19 | -0.17 | 0.40 | -0.05 | -0.07 | -0.24 | -0.51 | 0.18 | ||
Net Cash Flow | -0.03 | -0.14 | 0.49 | -0.44 | -0.03 | 0.15 | 0.13 | -0.22 | 0.04 | 1.12 | 0.04 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 91.83 | 182.11 | 241.44 | 184.28 | 261.39 | 21.67 | 16.89 | 23.64 | 45.57 | 93.45 | 26.47 | 93.50 |
Inventory Days | 116.33 | 131.63 | 117.88 | 46.16 | 101.43 | 95.13 | 66.63 | 57.65 | 59.10 | 120.11 | 306.47 | 610.67 |
Days Payable | 39.03 | 13.04 | 12.18 | 7.20 | 4.14 | 2.93 | 2.19 | 3.98 | 11.48 | 28.24 | 19.51 | 63.17 |
Cash Conversion Cycle | 169.13 | 300.69 | 347.14 | 223.24 | 358.68 | 113.87 | 81.33 | 77.31 | 93.20 | 185.32 | 313.43 | 641.00 |
Working Capital Days | 190.55 | 279.39 | 340.21 | 263.39 | 429.31 | 178.84 | 125.12 | 114.82 | 139.21 | 262.48 | 291.22 | 511.24 |
ROCE % | -5.55% | 0.60% | 0.33% | -14.51% | 1.13% | 2.08% | 2.87% | 2.80% | 1.84% | 1.59% | -24.93% | 1.23% |
Documents
Announcements
- Certificate Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (LODR) Regulations, 2015 2d
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - Certificate under regulation 74(5) SEBI (D&P) Regulation, 2015 for the quarter ended March 31, 2024
- Closure of Trading Window 27 Mar
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 22 Mar
-
Announcement under Regulation 30 (LODR)-Allotment
21 Mar - Conversion of 810826 Convertible Warrants into 810826 Equity Shares of Rs.10 each at a price not less than Rs. 15/- to Promoter Mr.Jay Kothari.
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2007
from bse
-
Financial Year 2006
from bse
Product Profile:[1][2]
Panjon Tablet, Panjon Balm, Panjon Cough Syrup, Panjon Cough Drops, Panjon Inhaler, Hinkargiri Hair Oil, Kery, Percy, Swad, Swad Awla, Swad Khajoor, Swad Chatpati, Swad Shoppee, Swad Energy Drink, Panjon Dental Cream, Purti Mouth Freshner
Distribution Network:[3]
Company markets and manufactures its products and undertakes contract manufacturing for MNCs. Company sells its formulations under own brand name, through a nationwide marketing network of 20+ states through a chain of 80 distributors who in turn sell goods to 1000 appointed stockiest and 4,50,000 retailers, with help of a field force of 300+ sales representatives